{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:24:52Z","timestamp":1794367492051,"version":"4.9.0"},"reference-count":181,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["19401900500"],"award-info":[{"award-number":["19401900500"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFC2005502"],"award-info":[{"award-number":["2020YFC2005502"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.biopha.2023.115670","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T23:42:32Z","timestamp":1697154152000},"page":"115670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":136,"special_numbering":"C","title":["Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects"],"prefix":"10.1016","volume":"168","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7921-2863","authenticated-orcid":false,"given":"Xiandeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2921-1015","authenticated-orcid":false,"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.115670_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin. Pr."},{"issue":"12","key":"10.1016\/j.biopha.2023.115670_bib2","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"10225","key":"10.1016\/j.biopha.2023.115670_bib3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Global, regional, and national burden of chronic kidney disease","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.biopha.2023.115670_bib4","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1053\/j.ajkd.2017.10.026","article-title":"Update on diabetic nephropathy: core curriculum 2018","volume":"71","author":"Umanath","year":"2018","journal-title":"Am. J. Kidney Dis."},{"issue":"5","key":"10.1016\/j.biopha.2023.115670_bib5","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2337\/dc15-2338","article-title":"Variations in diabetes prevalence in low-, middle-, and high-income countries: results from the prospective urban and rural epidemiological study","volume":"39","author":"Dagenais","year":"2016","journal-title":"Diabetes Care"},{"issue":"10027","key":"10.1016\/j.biopha.2023.115670_bib6","first-page":"1513","article-title":"a pooled analysis of 751 population-based studies with 4.4 million participants","volume":"387","author":"Worldwide trends in diabetes since 1980","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.biopha.2023.115670_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11892-021-01387-3","article-title":"The prevalence of diabetic microvascular complications in China and the USA","volume":"21","author":"Lin","year":"2021","journal-title":"Curr. Diab Rep."},{"issue":"3","key":"10.1016\/j.biopha.2023.115670_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10198-016-0773-6","article-title":"Cost of diabetic eye, renal and foot complications: a methodological review","volume":"18","author":"Schirr-Bonnans","year":"2017","journal-title":"Eur. J. Health Econ."},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2337\/dc20-0493","article-title":"Depression is associated with progression of diabetic nephropathy in type 1 diabetes","volume":"44","author":"Ahola","year":"2021","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.biopha.2023.115670_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020647","article-title":"How do type 2 diabetes mellitus (T2DM)-related complications and socioeconomic factors impact direct medical costs? A cross-sectional study in rural Southeast China","volume":"8","author":"Wu","year":"2018","journal-title":"BMJ Open"},{"issue":"3 Suppl 1","key":"10.1016\/j.biopha.2023.115670_bib11","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2018.01.002","article-title":"US renal data system 2017 annual data report: epidemiology of kidney disease in the United States","volume":"71","author":"Saran","year":"2018","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.biopha.2023.115670_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11892-019-1133-6","article-title":"The global burden of diabetic kidney disease: time trends and gender gaps","volume":"19","author":"Thomas","year":"2019","journal-title":"Curr. Diabetes Rep."},{"issue":"6","key":"10.1016\/j.biopha.2023.115670_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21062218","article-title":"Glucose and blood pressure-dependent pathways-the progression of Diabetic Kidney disease","volume":"21","author":"Patel","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2023.115670_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.14007","article-title":"An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines","volume":"22","author":"Selby","year":"2020","journal-title":"Diabetes Obes. Metab."},{"issue":"4","key":"10.1016\/j.biopha.2023.115670_bib15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"New Engl. J. Med."},{"issue":"24","key":"10.1016\/j.biopha.2023.115670_bib16","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"New Engl. J. Med."},{"issue":"7","key":"10.1016\/j.biopha.2023.115670_bib17","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"New Engl. J. Med."},{"issue":"24","key":"10.1016\/j.biopha.2023.115670_bib18","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.biopha.2023.115670_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/604208","article-title":"Redox signaling in diabetic nephropathy: hypertrophy versus death choices in mesangial cells and podocytes","volume":"2015","author":"Manda","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2023.115670_bib20","doi-asserted-by":"crossref","first-page":"8637138","DOI":"10.1155\/2017\/8637138","article-title":"Classification and differential diagnosis of diabetic nephropathy","volume":"2017","author":"Qi","year":"2017","journal-title":"J. Diabetes Res"},{"issue":"7","key":"10.1016\/j.biopha.2023.115670_bib21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41419-019-1754-3","article-title":"PGRN acts as a novel regulator of mitochondrial homeostasis by facilitating mitophagy and mitochondrial biogenesis to prevent podocyte injury in diabetic nephropathy","volume":"10","author":"Zhou","year":"2019","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.biopha.2023.115670_bib22","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.kint.2016.01.012","article-title":"Podocyte injury and its consequences","volume":"89","author":"Nagata","year":"2016","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.biopha.2023.115670_bib23","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1681\/ASN.2018050490","article-title":"What is the glomerular ultrafiltration barrier?","volume":"29","author":"Fissell","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41572-020-0196-7","article-title":"Podocytopathies","volume":"6","author":"Kopp","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"7","key":"10.1016\/j.biopha.2023.115670_bib25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1042\/CS20210625","article-title":"Mechanisms of podocyte injury and implications for diabetic nephropathy","volume":"136","author":"Barutta","year":"2022","journal-title":"Clin. Sci. (Lond. )"},{"key":"10.1016\/j.biopha.2023.115670_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-981-13-8871-2_10","article-title":"Role of podocyte injury in glomerulosclerosis","volume":"1165","author":"Lu","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115670_bib27","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.kint.2017.12.028","article-title":"Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases","volume":"93","author":"Sever","year":"2018","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.biopha.2023.115670_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031699","article-title":"Imaging the kidney with an unconventional scanning electron microscopy technique: analysis of the subpodocyte space in diabetic mice","volume":"23","author":"Conti","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2023.115670_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072632","article-title":"Lipotoxicity and diabetic nephropathy: novel mechanistic insights and therapeutic opportunities","volume":"21","author":"Opazo-R\u00edos","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2023.115670_bib30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41581-018-0001-y","article-title":"CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease","volume":"14","author":"Anders","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115670_bib31","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2215\/CJN.14831218","article-title":"Early glomerular hyperfiltration and long-term kidney outcomes in type 1 diabetes: the DCCT\/EDIC experience","volume":"14","author":"Molitch","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115670_bib32","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1681\/ASN.2016060666","article-title":"Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment","volume":"28","author":"Tonneijck","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2023.115670_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.106153","article-title":"A comprehensive insight into autophagy and its potential signaling pathways as a therapeutic target in podocyte injury","volume":"143","author":"Teh","year":"2022","journal-title":"Int J. Biochem Cell Biol."},{"key":"10.1016\/j.biopha.2023.115670_bib34","article-title":"Podocyte injury in diabetic kidney disease: a focus on mitochondrial dysfunction","volume":"10","author":"Liu","year":"2022","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2023.115670_bib35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.cca.2019.07.005","article-title":"Mitochondrial dysfunction in diabetic kidney disease","volume":"496","author":"Wei","year":"2019","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41467-017-00498-4","article-title":"Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.biopha.2023.115670_bib37","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1042\/CS20190372","article-title":"Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease","volume":"133","author":"Guo","year":"2019","journal-title":"Clin. Sci. (Lond. )"},{"issue":"4","key":"10.1016\/j.biopha.2023.115670_bib38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11154-019-09512-0","article-title":"Dietary lipids, gut microbiota and lipid metabolism","volume":"20","author":"Schoeler","year":"2019","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"3","key":"10.1016\/j.biopha.2023.115670_bib39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41580-018-0085-z","article-title":"Dynamics and functions of lipid droplets","volume":"20","author":"Olzmann","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"18","key":"10.1016\/j.biopha.2023.115670_bib40","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1016\/j.molcel.2021.08.027","article-title":"Lipid metabolism in sickness and in health: emerging regulators of lipotoxicity","volume":"81","author":"Yoon","year":"2021","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.biopha.2023.115670_bib41","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00509.2020","article-title":"Lipotoxicity dysregulates the immunoproteasome in podocytes and kidneys in type 2 diabetes","volume":"320","author":"Lee","year":"2021","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-022-01257-8","article-title":"The sirtuin family in health and disease","volume":"7","author":"Wu","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2023.115670_bib43","article-title":"Targeting SREBP-1-mediated lipogenesis as potential strategies for cancer","volume":"12","author":"Zhao","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115670_bib44","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.cmet.2020.10.019","article-title":"Elevation of JAML promotes diabetic kidney disease by modulating podocyte lipid metabolism","volume":"32","author":"Fu","year":"2020","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib45","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/jcp.29890","article-title":"Carbohydrate response element-binding protein regulates lipid metabolism via mTOR complex1 in diabetic nephropathy","volume":"236","author":"Chen","year":"2021","journal-title":"J. Cell Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115670_bib46","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.kint.2020.06.040","article-title":"Sterol-O-acyltransferase-1 has a role in kidney disease associated with diabetes and Alport syndrome","volume":"98","author":"Liu","year":"2020","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.biopha.2023.115670_bib47","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.kint.2020.07.008","article-title":"The ins-and-outs of podocyte lipid metabolism","volume":"98","author":"Meyer-Schwesinger","year":"2020","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.7150\/ijbs.64665","article-title":"GPR43 activation-mediated lipotoxicity contributes to podocyte injury in diabetic nephropathy by modulating the ERK\/EGR1 pathway","volume":"18","author":"Lu","year":"2022","journal-title":"Int J. Biol. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2023.115670_bib49","doi-asserted-by":"crossref","first-page":"23559","DOI":"10.1002\/jcp.28924","article-title":"Small GTPase Arf6 regulates diabetes-induced cholesterol accumulation in podocytes","volume":"234","author":"Hu","year":"2019","journal-title":"J. Cell Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115670_bib50","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13229","article-title":"Alteration in Rab11-mediated endocytic trafficking of LDL receptor contributes to angiotensin II-induced cholesterol accumulation and injury in podocytes","volume":"55","author":"Hu","year":"2022","journal-title":"Cell Prolif."},{"issue":"16","key":"10.1016\/j.biopha.2023.115670_bib51","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.7150\/thno.45003","article-title":"Sirt6 deficiency aggravates angiotensin II-induced cholesterol accumulation and injury in podocytes","volume":"10","author":"Yang","year":"2020","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.biopha.2023.115670_bib52","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cmet.2017.01.004","article-title":"Reducing VEGF-B signaling ameliorates renal lipotoxicity and protects against diabetic kidney disease","volume":"25","author":"Falkevall","year":"2017","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.biopha.2023.115670_bib53","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","article-title":"PPAR control of metabolism and cardiovascular functions","volume":"18","author":"Montaigne","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib54","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s42003-022-03300-4","article-title":"ROCK2-induced metabolic rewiring in diabetic podocytopathy","volume":"5","author":"Matoba","year":"2022","journal-title":"Commun. Biol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115670_bib55","article-title":"The protective role of peroxisome proliferator-activated receptor gamma in lipotoxic podocytes","volume":"1868","author":"Carrasco","year":"2023","journal-title":"Biochim Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"21","key":"10.1016\/j.biopha.2023.115670_bib56","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2016.08.050","article-title":"Differentiation of constriction and restriction: complex cardiovascular hemodynamics","volume":"68","author":"Geske","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115670_bib57","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.kint.2021.08.003","article-title":"Gains in understanding of podocyte loss","volume":"100","author":"Fogo","year":"2021","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib58","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000499486","article-title":"Consequences of glomerular hyperfiltration: the role of physical forces in the pathogenesis of chronic kidney disease in diabetes and obesity","volume":"143","author":"Chagnac","year":"2019","journal-title":"Nephron"},{"issue":"5","key":"10.1016\/j.biopha.2023.115670_bib59","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.kint.2021.06.040","article-title":"A mathematical estimation of the physical forces driving podocyte detachment","volume":"100","author":"Butt","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.biopha.2023.115670_bib60","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3389\/fendo.2018.00418","article-title":"Angiotensin II modulates podocyte glucose transport","volume":"9","author":"Lewko","year":"2018","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.biopha.2023.115670_bib61","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fendo.2014.00151","article-title":"Molecular and cellular events mediating glomerular podocyte dysfunction and depletion in diabetes mellitus","volume":"5","author":"Anil Kumar","year":"2014","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.biopha.2023.115670_bib62","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00125-020-05297-z","article-title":"Urinary podocyte-derived microparticles in youth with type 1 and type 2 diabetes","volume":"64","author":"Sullivan","year":"2021","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.biopha.2023.115670_bib63","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41581-022-00648-y","article-title":"Nutrient-sensing mTORC1 and AMPK pathways in chronic kidney diseases","volume":"19","author":"Huynh","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115670_bib64","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.2337\/db12-1504","article-title":"Mammalian target of rapamycin regulates Nox4-mediated podocyte depletion in diabetic renal injury","volume":"62","author":"Eid","year":"2013","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.biopha.2023.115670_bib65","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/jcp.31023","article-title":"Research progress on the role of ET-1 in diabetic kidney disease","volume":"238","author":"Zhang","year":"2023","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.biopha.2023.115670_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154890","article-title":"Kidney disease in diabetes: from mechanisms to clinical presentation and treatment strategies","volume":"124","author":"Ricciardi","year":"2021","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib67","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96968","article-title":"Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes","volume":"3","author":"Lovshin","year":"2018","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.biopha.2023.115670_bib68","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1053\/j.ajkd.2018.12.034","article-title":"Renal hemodynamic function and RAAS activation over the natural history of type 1 diabetes","volume":"73","author":"Lytvyn","year":"2019","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib69","doi-asserted-by":"crossref","first-page":"7679","DOI":"10.1038\/s41598-019-44194-3","article-title":"Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease","volume":"9","author":"Kang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115670_bib70","doi-asserted-by":"crossref","first-page":"17637","DOI":"10.1038\/srep17637","article-title":"Podocyte injury in diabetic nephropathy: implications of angiotensin II-dependent activation of TRPC channels","volume":"5","author":"Ilatovskaya","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib71","doi-asserted-by":"crossref","first-page":"15910","DOI":"10.1038\/s41598-017-15844-1","article-title":"The WD40-domain containing protein CORO2B is specifically enriched in glomerular podocytes and regulates the ventral actin cytoskeleton","volume":"7","author":"Rogg","year":"2017","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.biopha.2023.115670_bib72","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1617004114","article-title":"The FERM protein EPB41L5 regulates actomyosin contractility and focal adhesion formation to maintain the kidney filtration barrier","volume":"114","author":"Schell","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.biopha.2023.115670_bib73","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","article-title":"Targeting oxidative stress in disease: promise and limitations of antioxidant therapy","volume":"20","author":"Forman","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.biopha.2023.115670_bib74","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1096\/fj.201801921R","article-title":"High glucose-induced ubiquitination of G6PD leads to the injury of podocytes","volume":"33","author":"Wang","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2023.115670_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119529","article-title":"Sp1-mediated upregulation of Prdx6 expression prevents podocyte injury in diabetic nephropathy via mitigation of oxidative stress and ferroptosis","volume":"278","author":"Zhang","year":"2021","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.biopha.2023.115670_bib76","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.kint.2017.12.008","article-title":"Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury","volume":"93","author":"Hong","year":"2018","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.biopha.2023.115670_bib77","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41419-022-05120-0","article-title":"Sestrin2 remedies podocyte injury via orchestrating TSP-1\/TGF-\u03b21\/Smad3 axis in diabetic kidney disease","volume":"13","author":"Song","year":"2022","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.biopha.2023.115670_bib78","doi-asserted-by":"crossref","first-page":"701","DOI":"10.7150\/ijbs.29323","article-title":"Sirt6 suppresses high glucose-induced mitochondrial dysfunction and apoptosis in podocytes through ampk activation","volume":"15","author":"Fan","year":"2019","journal-title":"Int J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2023.115670_bib79","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.kint.2018.10.032","article-title":"Wnt\/\u03b2-catenin links oxidative stress to podocyte injury and proteinuria","volume":"95","author":"Zhou","year":"2019","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.biopha.2023.115670_bib80","doi-asserted-by":"crossref","first-page":"13300","DOI":"10.1096\/fj.202000783R","article-title":"FOXO3a accumulation and activation accelerate oxidative stress-induced podocyte injury","volume":"34","author":"Chen","year":"2020","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.biopha.2023.115670_bib81","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.3382\/ps\/pey407","article-title":"From oxidative stress to inflammation: redox balance and immune system","volume":"98","author":"Lauridsen","year":"2019","journal-title":"Poult. Sci."},{"key":"10.1016\/j.biopha.2023.115670_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102033","article-title":"Epigenetic regulation of TXNIP-mediated oxidative stress and NLRP3 inflammasome activation contributes to SAHH inhibition-aggravated diabetic nephropathy","volume":"45","author":"Dai","year":"2021","journal-title":"Redox Biol."},{"issue":"11","key":"10.1016\/j.biopha.2023.115670_bib83","doi-asserted-by":"crossref","first-page":"20869","DOI":"10.1002\/jcp.28691","article-title":"miR-15b-5p ameliorated high glucose-induced podocyte injury through repressing apoptosis, oxidative stress, and inflammatory responses by targeting Sema3A","volume":"234","author":"Fu","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.biopha.2023.115670_bib84","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.freeradbiomed.2019.01.009","article-title":"Pharmacological levels of hydrogen sulfide inhibit oxidative cell injury through regulating the redox state of thioredoxin","volume":"134","author":"Mao","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2023.115670_bib85","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.kint.2021.04.036","article-title":"Receptor activator of NF-\u03baB mediates podocyte injury in diabetic nephropathy","volume":"100","author":"Ke","year":"2021","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib86","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41467-023-37836-8","article-title":"Non-functional ubiquitin C-terminal hydrolase L1 drives podocyte injury through impairing proteasomes in autoimmune glomerulonephritis","volume":"14","author":"Reichelt","year":"2023","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biopha.2023.115670_bib87","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/17435390.2018.1513093","article-title":"Activated iRhom2 drives prolonged PM(2.5) exposure-triggered renal injury in Nrf2-defective mice","volume":"12","author":"Xu","year":"2018","journal-title":"Nanotoxicology"},{"issue":"2","key":"10.1016\/j.biopha.2023.115670_bib88","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/febs.13820","article-title":"Mitochondrial biogenesis and clearance: a balancing act","volume":"284","author":"Ploumi","year":"2017","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib89","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqab234","article-title":"Podocyte bioenergetics in the development of diabetic nephropathy: the role of mitochondria","volume":"163","author":"Audzeyenka","year":"2022","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib90","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1096\/fj.201600293r","article-title":"High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy","volume":"31","author":"Imasawa","year":"2017","journal-title":"Faseb J."},{"issue":"2","key":"10.1016\/j.biopha.2023.115670_bib91","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201948781","article-title":"Smad4 promotes diabetic nephropathy by modulating glycolysis and OXPHOS","volume":"21","author":"Li","year":"2020","journal-title":"EMBO Rep."},{"issue":"8","key":"10.1016\/j.biopha.2023.115670_bib92","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1172\/JCI125316","article-title":"ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes","volume":"129","author":"Ducasa","year":"2019","journal-title":"J. Clin. Invest"},{"issue":"9","key":"10.1016\/j.biopha.2023.115670_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094827","article-title":"Mitochondrial dysfunction in podocytes caused by CRIF1 deficiency leads to progressive albuminuria and glomerular sclerosis in mice","volume":"22","author":"Na","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2023.115670_bib94","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.cmet.2018.03.003","article-title":"Mitochondria bound to lipid droplets have unique bioenergetics, composition, and dynamics that support lipid droplet expansion","volume":"27","author":"Benador","year":"2018","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.biopha.2023.115670_bib95","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/15548627.2017.1283084","article-title":"Stagnation of autophagy: a novel mechanism of renal lipotoxicity","volume":"13","author":"Takabatake","year":"2017","journal-title":"Autophagy"},{"issue":"6","key":"10.1016\/j.biopha.2023.115670_bib96","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00109-022-02204-4","article-title":"PTEN-induced kinase 1 deficiency alters albumin permeability and insulin signaling in podocytes","volume":"100","author":"Audzeyenka","year":"2022","journal-title":"J. Mol. Med (Berl. )"},{"issue":"10","key":"10.1016\/j.biopha.2023.115670_bib97","doi-asserted-by":"crossref","first-page":"7433","DOI":"10.1002\/jcp.29646","article-title":"AKAP1 mediates high glucose-induced mitochondrial fission through the phosphorylation of Drp1 in podocytes","volume":"235","author":"Chen","year":"2020","journal-title":"J. Cell Physiol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115670_bib98","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41419-020-03022-7","article-title":"Increased long noncoding RNA maternally expressed gene 3 contributes to podocyte injury induced by high glucose through regulation of mitochondrial fission","volume":"11","author":"Deng","year":"2020","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.biopha.2023.115670_bib99","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00285.2020","article-title":"Mitochondrial dysfunction and the AKI-to-CKD transition","volume":"319","author":"Jiang","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"14","key":"10.1016\/j.biopha.2023.115670_bib100","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92930","article-title":"Increasing the level of peroxisome proliferator-activated receptor \u03b3 coactivator-1\u03b1 in podocytes results in collapsing glomerulopathy","volume":"2","author":"Li","year":"2017","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.biopha.2023.115670_bib101","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.diabet.2015.02.002","article-title":"Metabolic roles of PGC-1\u03b1 and its implications for type 2 diabetes","volume":"41","author":"Besseiche","year":"2015","journal-title":"Diabetes Metab."},{"issue":"3","key":"10.1016\/j.biopha.2023.115670_bib102","first-page":"4490","article-title":"PGC-1\u03b1 ameliorates kidney fibrosis in mice with diabetic kidney disease through an antioxidative mechanism","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2023.115670_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054696","article-title":"Placental mesenchymal stem cells alleviate podocyte injury in diabetic kidney disease by modulating mitophagy via the SIRT1-PGC-1alpha-TFAM pathway","volume":"24","author":"Han","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2023.115670_bib104","doi-asserted-by":"crossref","first-page":"15123","DOI":"10.1002\/jcp.28153","article-title":"Deregulation of long noncoding RNA (TUG1) contributes to excessive podocytes apoptosis by activating endoplasmic reticulum stress in the development of diabetic nephropathy","volume":"234","author":"Shen","year":"2019","journal-title":"J. Cell Physiol."},{"issue":"10","key":"10.1016\/j.biopha.2023.115670_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105145","article-title":"cGAS-STING activation contributes to podocyte injury in diabetic kidney disease","volume":"25","author":"Zang","year":"2022","journal-title":"iScience"},{"issue":"6","key":"10.1016\/j.biopha.2023.115670_bib106","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41580-018-0003-4","article-title":"Mechanism and medical implications of mammalian autophagy","volume":"19","author":"Dikic","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115670_bib107","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2337\/db15-0473","article-title":"Impaired podocyte autophagy exacerbates proteinuria in diabetic nephropathy","volume":"65","author":"Tagawa","year":"2016","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.biopha.2023.115670_bib108","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41581-020-0309-2","article-title":"Autophagy in kidney homeostasis and disease","volume":"16","author":"Tang","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"issue":"10","key":"10.1016\/j.biopha.2023.115670_bib109","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41419-021-04156-y","article-title":"METTL14 aggravates podocyte injury and glomerulopathy progression through N(6)-methyladenosine-dependent downregulating of Sirt1","volume":"12","author":"Lu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib110","first-page":"23","article-title":"Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy","volume":"9","author":"Su","year":"2022","journal-title":"Mil. Med Res"},{"key":"10.1016\/j.biopha.2023.115670_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.624989","article-title":"Silencing of miR-150-5p ameliorates diabetic nephropathy by targeting SIRT1\/p53\/AMPK pathway","volume":"12","author":"Dong","year":"2021","journal-title":"Front Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115670_bib112","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s13105-020-00737-1","article-title":"Liver X receptor activation induces podocyte injury via inhibiting autophagic activity","volume":"76","author":"Zhang","year":"2020","journal-title":"J. Physiol. Biochem"},{"issue":"2","key":"10.1016\/j.biopha.2023.115670_bib113","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12738","article-title":"SPAG5-AS1 inhibited autophagy and aggravated apoptosis of podocytes via SPAG5\/AKT\/mTOR pathway","volume":"53","author":"Xu","year":"2020","journal-title":"Cell Prolif."},{"issue":"2","key":"10.1016\/j.biopha.2023.115670_bib114","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202001143R","article-title":"sPLA2-IB and PLA2R mediate insufficient autophagy and contribute to podocyte injury in idiopathic membranous nephropathy by activation of the p38MAPK\/mTOR\/ULK1(ser757) signaling pathway","volume":"35","author":"Yang","year":"2021","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.biopha.2023.115670_bib115","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2337\/db20-0660","article-title":"Podocyte EGFR inhibits autophagy through upregulation of rubicon in type 2 diabetic nephropathy","volume":"70","author":"Li","year":"2021","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.biopha.2023.115670_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166705","article-title":"UCP2 deficiency impairs podocyte autophagy in diabetic nephropathy","volume":"1869","author":"Yang","year":"2023","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"issue":"2","key":"10.1016\/j.biopha.2023.115670_bib117","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/15548627.2022.2080382","article-title":"Protective effect of the tunneling nanotube-TNFAIP2\/M-sec system on podocyte autophagy in diabetic nephropathy","volume":"19","author":"Barutta","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2023.115670_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118794","article-title":"LncRNA MALAT1\/microRNA let-7f\/KLF5 axis regulates podocyte injury in diabetic nephropathy","volume":"266","author":"Zhang","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2023.115670_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155155","article-title":"cAMP-response element binding protein mediates podocyte injury in diabetic nephropathy by targeting lncRNA DLX6-AS1","volume":"129","author":"Zheng","year":"2022","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.biopha.2023.115670_bib120","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41419-023-05695-2","article-title":"Long non-coding RNA DLX6-AS1 is the key mediator of glomerular podocyte injury and albuminuria in diabetic nephropathy by targeting the miR-346\/GSK-3\u03b2 signaling pathway","volume":"14","author":"Guo","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2023.115670_bib121","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.omtn.2022.03.001","article-title":"Inhibition of the lncRNA MIAT prevents podocyte injury and mitotic catastrophe in diabetic nephropathy","volume":"28","author":"Wang","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"4","key":"10.1016\/j.biopha.2023.115670_bib122","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/ars.2017.7278","article-title":"Long noncoding RNA LINC01619 regulates microRNA-27a\/forkhead box protein O1 and endoplasmic reticulum stress-mediated podocyte injury in diabetic nephropathy","volume":"29","author":"Bai","year":"2018","journal-title":"Antioxid. Redox Signal"},{"issue":"2","key":"10.1016\/j.biopha.2023.115670_bib123","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41419-023-05658-7","article-title":"Long noncoding RNA ENST00000436340 promotes podocyte injury in diabetic kidney disease by facilitating the association of PTBP1 with RAB3B","volume":"14","author":"Hu","year":"2023","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.biopha.2023.115670_bib124","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41401-020-00525-z","article-title":"Caspase-11\/4 and gasdermin D-mediated pyroptosis contributes to podocyte injury in mouse diabetic nephropathy","volume":"42","author":"Cheng","year":"2021","journal-title":"Acta Pharm. Sin."},{"issue":"3","key":"10.1016\/j.biopha.2023.115670_bib125","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00403.2020","article-title":"Long noncoding RNA Kcnq1ot1 promotes sC5b-9-induced podocyte pyroptosis by inhibiting miR-486a-3p and upregulating NLRP3","volume":"320","author":"Zhang","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115670_bib126","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1681\/ASN.2016111248","article-title":"The calcium-dependent protease calpain-1 links TRPC6 activity to podocyte injury","volume":"29","author":"Verheijden","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib127","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.kint.2022.02.029","article-title":"Non-canonical Wnt\/calcium signaling is protective against podocyte injury and glomerulosclerosis","volume":"102","author":"Zhou","year":"2022","journal-title":"Kidney Int"},{"issue":"28","key":"10.1016\/j.biopha.2023.115670_bib128","doi-asserted-by":"crossref","first-page":"14154","DOI":"10.1073\/pnas.1813580116","article-title":"Discovery of endoplasmic reticulum calcium stabilizers to rescue ER-stressed podocytes in nephrotic syndrome","volume":"116","author":"Park","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2023.115670_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111918","article-title":"New progress in drugs treatment of diabetic kidney disease","volume":"141","author":"Wang","year":"2021","journal-title":"Biomed. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2023.115670_bib130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneph.2017.31","article-title":"The role of the complement system in diabetic nephropathy","volume":"13","author":"Flyvbjerg","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.biopha.2023.115670_bib131","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.metabol.2018.02.004","article-title":"Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy","volume":"85","author":"Choi","year":"2018","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.biopha.2023.115670_bib132","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/08941939.2016.1278057","article-title":"Effect of simvastatin on lipid accumulation and the expression of CXCL16 and nephrin in podocyte induced by oxidized LDL","volume":"31","author":"Wang","year":"2018","journal-title":"J. Invest Surg."},{"issue":"18","key":"10.1016\/j.biopha.2023.115670_bib133","doi-asserted-by":"crossref","first-page":"8725","DOI":"10.1111\/jcmm.16828","article-title":"Dehydrozingerone inhibits renal lipotoxicity in high-fat diet-induced obese mice","volume":"25","author":"Lee","year":"2021","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.biopha.2023.115670_bib134","doi-asserted-by":"crossref","first-page":"6275505","DOI":"10.1155\/2022\/6275505","article-title":"Gandi capsule improved podocyte lipid metabolism of diabetic nephropathy mice through SIRT1\/AMPK\/HNF4A pathway","volume":"2022","author":"Zhang","year":"2022","journal-title":"Oxid. Med Cell Longev."},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib135","first-page":"123","article-title":"Resveratrol alleviates obesity-associated podocyte injury in ovariectomized obese rats","volume":"19","author":"Li","year":"2020","journal-title":"Exp. Ther. Med"},{"issue":"3","key":"10.1016\/j.biopha.2023.115670_bib136","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/1440-1681.12716","article-title":"Pitavastatin suppresses hyperglycaemia-induced podocyte injury via bone morphogenetic protein-7 preservation","volume":"44","author":"Ohigashi","year":"2017","journal-title":"Clin. Exp. Pharm. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115670_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.165610","article-title":"Metformin reduces TRPC6 expression through AMPK activation and modulates cytoskeleton dynamics in podocytes under diabetic conditions","volume":"1866","author":"Szrejder","year":"2020","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2023.115670_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115158","article-title":"A sulfonamide chalcone AMPK activator ameliorates hyperglycemia and diabetic nephropathy in db\/db mice","volume":"165","author":"Kaewin","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2023.115670_bib139","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00498.2019","article-title":"Beneficial effect on podocyte number in experimental diabetic nephropathy resulting from combined atrasentan and RAAS inhibition therapy","volume":"318","author":"Hudkins","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115670_bib140","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s11255-019-02074-9","article-title":"Spironolactone alleviates diabetic nephropathy through promoting autophagy in podocytes","volume":"51","author":"Dong","year":"2019","journal-title":"Int Urol. Nephrol."},{"key":"10.1016\/j.biopha.2023.115670_bib141","article-title":"Studies on the metabolism and mechanism of acteoside in treating chronic glomerulonephritis","author":"Gao","year":"2023","journal-title":"J. Ethnopharmacol. 302(Pt A)"},{"key":"10.1016\/j.biopha.2023.115670_bib142","doi-asserted-by":"crossref","first-page":"12273","DOI":"10.1038\/srep12273","article-title":"Salvianolic acid A as a multifunctional agent ameliorates doxorubicin-induced nephropathy in rats","volume":"5","author":"Fan","year":"2015","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2023.115670_bib143","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00614.2020","article-title":"Sacubitril\/valsartan treatment has differential effects in modulating diabetic kidney disease in db\/db mice and KKAy mice compared with valsartan treatment","volume":"320","author":"Myakala","year":"2021","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115670_bib144","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.bbrc.2016.12.050","article-title":"Glucagon-like peptide-1 inhibits the receptor for advanced glycation endproducts to prevent podocyte apoptosis induced by advanced oxidative protein products","volume":"482","author":"Zhang","year":"2017","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2023.115670_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109088","article-title":"Wedelolactone alleviates doxorubicin-induced inflammation and oxidative stress damage of podocytes by I\u03baK\/I\u03baB\/NF-\u03baB pathway","volume":"117","author":"Zhu","year":"2019","journal-title":"Biomed. Pharm."},{"issue":"9","key":"10.1016\/j.biopha.2023.115670_bib146","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1080\/10715762.2018.1500021","article-title":"Leonurine ameliorates adriamycin-induced podocyte injury via suppression of oxidative stress","volume":"52","author":"Liu","year":"2018","journal-title":"Free Radic. Res"},{"issue":"22","key":"10.1016\/j.biopha.2023.115670_bib147","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228577","article-title":"Tangeretin ameliorates glucose-induced podocyte injury through blocking epithelial to mesenchymal transition caused by oxidative stress and hypoxia","volume":"21","author":"Kang","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2023.115670_bib148","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/jcmm.16165","article-title":"Salvianolate ameliorates oxidative stress and podocyte injury through modulation of NOX4 activity in db\/db mice","volume":"25","author":"Liang","year":"2021","journal-title":"J. Cell Mol. Med"},{"issue":"10","key":"10.1016\/j.biopha.2023.115670_bib149","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102202","article-title":"Polydatin ameliorates high fructose-induced podocyte oxidative stress via suppressing HIF-1\u03b1\/NOX4 pathway","volume":"14","author":"Ding","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2023.115670_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119068","article-title":"Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPAR\u03b3-Klotho-FoxO1 axis in diabetic nephropathy","volume":"269","author":"Xing","year":"2021","journal-title":"Life Sci."},{"issue":"62","key":"10.1016\/j.biopha.2023.115670_bib151","doi-asserted-by":"crossref","first-page":"35413","DOI":"10.1039\/C8RA07935H","article-title":"Quercetin ameliorates podocyte injury via inhibition of oxidative stress and the TGF-\u03b21\/Smad pathway in DN rats","volume":"8","author":"Gao","year":"2018","journal-title":"RSC Adv."},{"issue":"5","key":"10.1016\/j.biopha.2023.115670_bib152","doi-asserted-by":"crossref","first-page":"12275","DOI":"10.1080\/21655979.2022.2067293","article-title":"Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p\/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy","volume":"13","author":"Gao","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.biopha.2023.115670_bib153","article-title":"Astragaloside II ameliorated podocyte injury and mitochondrial dysfunction in streptozotocin-induced diabetic rats","volume":"12","author":"Su","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2023.115670_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175136","article-title":"MitoTEMPO protects against podocyte injury by inhibiting NLRP3 inflammasome via PINK1\/Parkin pathway-mediated mitophagy","volume":"929","author":"Liu","year":"2022","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2023.115670_bib155","article-title":"Src activation aggravates podocyte injury in diabetic nephropathy via suppression of FUNDC1-mediated mitophagy","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2023.115670_bib156","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.992597","article-title":"Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease","volume":"13","author":"Wu","year":"2022","journal-title":"Front Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2023.115670_bib157","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.7150\/thno.30640","article-title":"Berberine protects glomerular podocytes via inhibiting Drp1-mediated mitochondrial fission and dysfunction","volume":"9","author":"Qin","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2023.115670_bib158","doi-asserted-by":"crossref","first-page":"1394486","DOI":"10.1155\/2021\/1394486","article-title":"Mitoquinone protects podocytes from angiotensin ii-induced mitochondrial dysfunction and injury via the keap1-Nrf2 signaling pathway","volume":"2021","author":"Zhu","year":"2021","journal-title":"Oxid. Med Cell Longev."},{"issue":"3","key":"10.1016\/j.biopha.2023.115670_bib159","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.kint.2019.03.023","article-title":"Mitochondrial biogenesis induced by the \u03b22-adrenergic receptor agonist formoterol accelerates podocyte recovery from glomerular injury","volume":"96","author":"Arif","year":"2019","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib160","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41598-023-27914-8","article-title":"\u03b2-Aminoisobutyric acid (L-BAIBA) is a novel regulator of mitochondrial biogenesis and respiratory function in human podocytes","volume":"13","author":"Audzeyenka","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115670_bib161","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.phymed.2018.10.031","article-title":"Salidroside stimulates the Sirt1\/PGC-1\u03b1 axis and ameliorates diabetic nephropathy in mice","volume":"54","author":"Xue","year":"2019","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib162","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13020-023-00738-4","article-title":"BaoShenTongLuo formula protects against podocyte injury by regulating AMPK-mediated mitochondrial biogenesis in diabetic kidney disease","volume":"18","author":"Guo","year":"2023","journal-title":"Chin. Med"},{"key":"10.1016\/j.biopha.2023.115670_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110206","article-title":"Dapagliflozin alleviates advanced glycation end product induced podocyte injury through AMPK\/mTOR mediated autophagy pathway","volume":"90","author":"Yang","year":"2022","journal-title":"Cell Signal"},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib164","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1080\/0886022X.2022.2063744","article-title":"Vitamin D\/vitamin D receptor\/Atg16L1 axis maintains podocyte autophagy and survival in diabetic kidney disease","volume":"44","author":"Shi","year":"2022","journal-title":"Ren. Fail"},{"key":"10.1016\/j.biopha.2023.115670_bib165","doi-asserted-by":"crossref","DOI":"10.1159\/000530403","article-title":"Vitamin D ameliorates podocyte injury by enhancing autophagy activity in diabetic kidney disease","author":"Zhang","year":"2023","journal-title":"Kidney Blood Press Res"},{"issue":"11","key":"10.1016\/j.biopha.2023.115670_bib166","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00109-019-01828-3","article-title":"Progranulin alleviates podocyte injury via regulating CAMKK\/AMPK-mediated autophagy under diabetic conditions","volume":"97","author":"Zhou","year":"2019","journal-title":"J. Mol. Med (Berl. )"},{"key":"10.1016\/j.biopha.2023.115670_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115246","article-title":"Jiedu Tongluo Baoshen formula enhances podocyte autophagy and reduces proteinuria in diabetic kidney disease by inhibiting PI3K\/Akt\/mTOR signaling pathway","volume":"293","author":"Jin","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2023.115670_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110479","article-title":"Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K\/AKT\/mTOR pathways to protect against diabetic nephropathy in mice","volume":"129","author":"Yang","year":"2020","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2023.115670_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154400","article-title":"Paeoniflorin binds to VEGFR2 to restore autophagy and inhibit apoptosis for podocyte protection in diabetic kidney disease through PI3K-AKT signaling pathway","volume":"106","author":"Wang","year":"2022","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib170","first-page":"115","article-title":"Tripterygium glycoside protects against puromycin amino nucleoside\u2011induced podocyte injury by upregulating autophagy","volume":"42","author":"Gong","year":"2018","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.biopha.2023.115670_bib171","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.biopha.2018.05.017","article-title":"Hispidulin alleviates high-glucose-induced podocyte injury by regulating protective autophagy","volume":"104","author":"Wu","year":"2018","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2023.115670_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114675","article-title":"Sarsasapogenin restores podocyte autophagy in diabetic nephropathy by targeting GSK3\u03b2 signaling pathway","volume":"192","author":"Li","year":"2021","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2023.115670_bib173","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3389\/fphar.2019.01477","article-title":"Catalpol ameliorates podocyte injury by stabilizing cytoskeleton and enhancing autophagy in diabetic nephropathy","volume":"10","author":"Chen","year":"2019","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2023.115670_bib174","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2147\/DMSO.S298950","article-title":"Atorvastatin regulates MALAT1\/miR-200c\/NRF2 activity to protect against podocyte pyroptosis induced by high glucose","volume":"14","author":"Zuo","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.biopha.2023.115670_bib175","article-title":"Total flavones of abelmoschus manihot ameliorates podocyte pyroptosis and injury in high glucose conditions by targeting METTL3-Dependent m(6)A modification-mediated nlrp3-inflammasome activation and PTEN\/PI3K\/Akt signaling","volume":"12","author":"Liu","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2023.115670_bib176","article-title":"Fucoidan alleviates renal fibrosis in diabetic kidney disease via inhibition of NLRP3 inflammasome-mediated podocyte pyroptosis","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharm."},{"issue":"Pt B","key":"10.1016\/j.biopha.2023.115670_bib177","article-title":"Carnosine alleviates podocyte injury in diabetic nephropathy by targeting caspase-1-mediated pyroptosis","volume":"101","author":"Zhu","year":"2021","journal-title":"Int Immunopharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115670_bib178","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cmet.2020.06.020","article-title":"SGLT2 inhibition mediates protection from diabetic kidney disease by promoting ketone body-induced mTORC1 inhibition","volume":"32","author":"Tomita","year":"2020","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.biopha.2023.115670_bib179","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/cea.13326","article-title":"Pharmacogenetics of angiotensin-converting enzyme inhibitor-induced angioedema","volume":"49","author":"Liau","year":"2019","journal-title":"Clin. Exp. Allergy"},{"issue":"2","key":"10.1016\/j.biopha.2023.115670_bib180","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/FJC.0000000000001049","article-title":"Adverse events of sacubitril\/valsartan: a meta-analysis of randomized controlled trials","volume":"78","author":"Huang","year":"2021","journal-title":"J. Cardiovasc Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2023.115670_bib181","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jbspin.2019.01.018","article-title":"Statins, myalgia, and rhabdomyolysis","volume":"87","author":"Tournadre","year":"2020","journal-title":"Jt. Bone Spine"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223014683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223014683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:42:19Z","timestamp":1779918139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223014683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":181,"alternative-id":["S0753332223014683"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115670","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115670","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115670"}}